scholarly article | Q13442814 |
P356 | DOI | 10.2337/DB06-0144 |
P698 | PubMed publication ID | 17192461 |
P50 | author | Makoto Kanzaki | Q42805760 |
P2093 | author name string | Hideki Katagiri | |
Yoshitomo Oka | |||
Shun Ishibashi | |||
Junta Imai | |||
Tetsuya Yamada | |||
Yasushi Ishigaki | |||
Kenji Uno | |||
Yutaka Hasegawa | |||
Junhong Gao | |||
Tokuo T Yamamoto | |||
Takehide Ogihara | |||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | insulin resistance | Q1053470 |
preproinsulin | Q7240673 | ||
P304 | page(s) | 24-33 | |
P577 | publication date | 2007-01-01 | |
P1433 | published in | Diabetes | Q895262 |
P1476 | title | Involvement of apolipoprotein E in excess fat accumulation and insulin resistance | |
P478 | volume | 56 |
Q92537636 | A Maternal High-Fat Diet Induces DNA Methylation Changes That Contribute to Glucose Intolerance in Offspring |
Q42848056 | A dysregulation in CES1, APOE and other lipid metabolism-related genes is associated to cardiovascular risk factors linked to obesity |
Q37325991 | A polymorphism of apolipoprotein E (APOE) gene is associated with age at natural menopause in Caucasian females |
Q51369429 | Altered endocannabinoid signalling after a high-fat diet in Apoe(-/-) mice: relevance to adipose tissue inflammation, hepatic steatosis and insulin resistance. |
Q37515725 | An accelerated mouse model for atherosclerosis and adipose tissue inflammation. |
Q35757087 | Antiobesity effect of eicosapentaenoic acid in high-fat/high-sucrose diet-induced obesity: importance of hepatic lipogenesis |
Q42261977 | ApoE and the role of very low density lipoproteins in adipose tissue inflammation |
Q35003338 | ApoE polymorphism may determine low-density lipoprotein cholesterol level in association with obesity and metabolic syndrome in postmenopausal Korean women |
Q36401998 | Apolipoprotein CIII overexpression exacerbates diet-induced obesity due to adipose tissue higher exogenous lipid uptake and retention and lower lipolysis rates |
Q33846064 | Apolipoprotein E deficiency abrogates insulin resistance in a mouse model of type 2 diabetes mellitus |
Q88708988 | Apolipoprotein E in diet-induced obesity: a paradigm shift from conventional perception |
Q41886031 | Apolipoprotein E knock-out and knock-in mice: atherosclerosis, metabolic syndrome, and beyond. |
Q38850449 | Apolipoprotein E promotes lipid accumulation and differentiation in human adipocytes |
Q34143697 | Apolipoprotein E synthesized by adipocyte and apolipoprotein E carried on lipoproteins modulate adipocyte triglyceride content |
Q42019558 | Apoprotein E as a lipid transport and signaling protein in the blood, liver, and artery wall |
Q46613786 | Association of cholesteryl ester transfer protein (TaqIB) and apolipoprotein E (HhaI) gene variants with obesity |
Q89841154 | Beyond the CNS: The many peripheral roles of APOE |
Q40037439 | Characterization of lipid metabolism in insulin-sensitive adipocytes differentiated from immortalized human mesenchymal stem cells |
Q35603166 | Critical role of chemokine (C-C motif) receptor 2 (CCR2) in the KKAy + Apoe -/- mouse model of the metabolic syndrome |
Q33585519 | Differential modulation of diet-induced obesity and adipocyte functionality by human apolipoprotein E3 and E4 in mice |
Q37060345 | Effect of Inorganic Dietary Selenium Supplementation on Selenoprotein and Lipid Metabolism Gene Expression Patterns in Liver and Loin Muscle of Growing Lambs |
Q38094875 | Genomic aspects of NAFLD pathogenesis. |
Q33913281 | H1-antihistamines exacerbate high-fat diet-induced hepatic steatosis in wild-type but not in apolipoprotein E knockout mice. |
Q30428421 | Hyperglycemia in apolipoprotein E-deficient mouse strains with different atherosclerosis susceptibility |
Q36806457 | Hyperinsulinemia does not change atherosclerosis development in apolipoprotein E null mice |
Q37331224 | Influence of apolipoproteins on the association between lipids and insulin sensitivity: a cross-sectional analysis of the RISC Study |
Q96230448 | Integrative phenotyping of glycemic responders upon clinical weight loss using multi-omics |
Q33510159 | LRP1 receptor controls adipogenesis and is up-regulated in human and mouse obese adipose tissue. |
Q37133627 | Large-scale association study for structural soundness and leg locomotion traits in the pig |
Q33553625 | Mechanism for endogenously expressed ApoE modulation of adipocyte very low density lipoprotein metabolism: role in endocytic and lipase-mediated metabolic pathways |
Q26800081 | Molecular Events Linking Oxidative Stress and Inflammation to Insulin Resistance and β-Cell Dysfunction |
Q33849244 | Mouse models of the metabolic syndrome |
Q37431634 | Peroxisome proliferator-activated receptor gamma agonist rosiglitazone increases expression of very low density lipoprotein receptor gene in adipocytes |
Q100316325 | Protective effect of pharmacological castration on metabolic perturbations and cardiovascular disease in the hyperglycemic male ApoE-/-:Ins2+/Akita mouse model |
Q37391895 | Role of adipocyte-derived apoE in modulating adipocyte size, lipid metabolism, and gene expression in vivo |
Q30357364 | STAT4 contributes to adipose tissue inflammation and atherosclerosis. |
Q30299994 | Variation in Type 2 Diabetes-Related Phenotypes among Apolipoprotein E-Deficient Mouse Strains |
Q37488539 | Very low density lipoprotein receptor (VLDLR) expression is a determinant factor in adipose tissue inflammation and adipocyte-macrophage interaction |
Search more.